Postbiotic Ingredient Market Report 2026

The postbiotic ingredient market size has grown rapidly in recent years. It will grow from $1.2 billion in 2025 to $1.33 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rising awareness of gut health benefits, increasing probiotic product adoption, growth in functional food consumption, expansion of dietary supplement industry, early research on microbiome health benefits.

The postbiotic ingredient market size is expected to see rapid growth in the next few years. It will grow to $2.02 billion by 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing demand for immune health support products, rising prevalence of lifestyle-related disorders, growing focus on preventive healthcare nutrition, expansion of personalized nutrition solutions, increasing investment in microbiome-based research and development. Major trends in the forecast period include increasing adoption of clean-label and natural postbiotic formulations in functional foods, growing integration of postbiotics in personalized nutrition and gut health solutions, rising use of fermentation-derived bioactive compounds in dietary supplements, expansion of microbiome-targeted product development in pharmaceutical applications, increasing demand for stable non-living probiotic alternatives in food and beverage innovation.

The rising demand for preventive healthcare options is expected to propel the growth of the postbiotic ingredient market going forward. Preventive healthcare options include measures and interventions aimed at reducing disease risk, promoting overall wellness, and enabling early detection of health conditions before they become severe. The increasing demand for preventive healthcare is driven by growing awareness of the benefits of early intervention, healthy lifestyles, and long-term disease prevention. Postbiotic ingredients support preventive healthcare by enhancing gut microbiome balance and strengthening immune and metabolic functions, thereby contributing to reduced risk of chronic diseases. For example, in November 2025, according to the Organization for Economic Co-operation and Development report Health at a Glance 2025, a France-based government agency, spending on preventive care accounted for approximately 3% of total health expenditure across OECD countries, indicating that preventive care remains a relatively small share of overall health spending. Therefore, the rising demand for preventive healthcare options is driving the growth of the postbiotic ingredient market.

Leading companies operating in the postbiotic ingredient market are focusing on shift towards clean-label formulations, such as rice-derived heat-inactivated postbiotics, to meet growing consumer demand for safe, transparent, and naturally derived functional ingredients. These ingredients are non-living microbial preparations designed to deliver gut and related wellness benefits with strong processing stability, simple label positioning, and broad compatibility across supplement, food, and beverage formats. For example, in February 2024, Kerry Group PLC, an Ireland-based taste and nutrition company, launched Plenibiotic. It is a rice-derived postbiotic ingredient that supports gut and skin health, offers stability across diverse temperature, moisture, and pH conditions, and works at a low serving size for formulation versatility across human and pet applications. These capabilities strengthen the relevance of clean-label formulation trends for the postbiotic ingredient market.

In June 2023, Biocodex, a France-based provider of microbiota care products, women’s health solutions, and orphan disease treatments, acquired TargEDys for an undisclosed amount. With this acquisition, Biocodex aimed to strengthen its microbiome portfolio, accelerate TargEDys’ development, and advance its strategic ambition to become a leader in microbiota care through microbiome-based innovation.

TargEDys is a France-based provider of microbiome-based nutraceutical solutions, including precision probiotic and postbiotic products for appetite control, weight management, undernutrition, and mental health support.

Major companies operating in the postbiotic ingredient market are Nestlé S. A., Unilever PLC, BASF SE, Danone S. A., Archer Daniels Midland (ADM), Givaudan SA, dsm-firmenich, Associated British Foods (ABF), CJ CheilJedang, International Flavors & Fragrances (IFF), Asahi Group Holdings, Kerry Group, Novonesis (NZYM. VI), Kirin Holdings, Evonik Industries AG, Croda International, Symrise AG, Clariant AG, Ashland Inc., Morinaga Milk Industry.

North America was the dominating region in the postbiotic ingredient market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the postbiotic ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the postbiotic ingredient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The postbiotic ingredients market consists of sales of products including Epicor, Ganedenbc30, Humiome Post LB, Lactobacillus postbiotic complex, and postbiotic digestive yeast blend. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.